Covenant Multifamily Offices’s PRA Health Sciences, Inc. PRAH Stock Holding History

Covenant Multifamily Offices’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,029	Closed	-$335K	–	252
2021 Q2	$335K	Hold	2,029	–	–	0.06%	169
2021 Q1	$311K	Hold	2,029	–	–	0.06%	144
2020 Q4	$255K	Sell	2,029 -157	-7%	-$17.6K	0.05%	119
2020 Q3	$222K	Sell	2,186 -906	-29%	-$92.4K	0.04%	112
2020 Q2	$301K	Buy	+3,092	New	+$288K	0.06%	122
2020 Q1	–	Sell	-3,152	Closed	-$313K	–	196
2019 Q4	$313K	Buy	3,152 +627	+25%	+$64.5K	0.05%	150
2019 Q3	$251K	Buy	2,525 +284	+13%	+$28.2K	0.05%	131
2019 Q2	$222K	Buy	+2,241	New	+$214K	0.05%	134

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Covenant Multifamily Offices's PRAH Position: Q3 2021 in Review

Covenant Multifamily Offices sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 2,029 shares — an estimated $335K sold.

Covenant Multifamily Offices first reported a position in PRAH in Q2 2019 and held it in 8 quarters. The position peaked at $335K in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Covenant Multifamily Offices reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Covenant Multifamily Offices sold 2,029 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $335K.
Covenant Multifamily Offices first reported a position in PRA Health Sciences, Inc. in Q2 2019 and held it in 8 quarters.
Covenant Multifamily Offices's PRA Health Sciences, Inc. position peaked at $335K in Q2 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Covenant Multifamily Offices's 13F filing for Q3 2021, filed 21 Oct 2021.